Through PDGF-bR/NLRP3/caspase1 pathway to reduce liver inflammation, and exerts antitumor effects by inducing apoptosis and autophagy in hepatocellular carcinoma, and inhibition of hepatic steatosis by activating the Nrf2 signaling pathway. This evidence concerns the gene NLRP3 and fatty liver disease.